Treatment Information

Back

Prostate Cancer treatment details. Biologic therapy.

The University of Chicago Comprehensive Cancer Centre, Chicago, Il, United States.

Survival: monthsCountry:United States
Toxiciy Grade:4City/State/Province:Chicago, Il
Treatments:Biologic therapyHospital:The University of Chicago Comprehensive Cancer Centre
Drugs:Journal:Link
Date:Feb 2014

Description:

Patients:
This phase 2 study involved 32 chemotherapy-naïve castration-resistant prostate cancer patients with an average age of 74 years.

Treatment:
Patients were treated with the biologic therapy agent called lenalidomide.

Toxicities:
The most severe toxicities were of grade 4 and included grade 3-4 fatigue, anemia, and electrolyte imbalance.

Results:
The median overall survival was 20 months.

Support:
This study was supported by Celgene Corp.

Correspondence: Dr. Chadi Nabhan; email: [email protected]



Back